Sanuwave Health Reports Q3 2026 Revenue Decline to $8.58 Million
Sanuwave Health (SNWV) reported third-quarter fiscal 2026 financial results characterized by a significant decline in both revenue and unit sales. The company posted GAAP earnings per share of -$0.16, while total revenue fell to $8.58 million, representing a 23.9% decrease compared to the same period last year. The downturn was driven largely by a sharp reduction in product volume; Sanuwave sold 40 Ultramist® systems during the quarter, a substantial drop from the 155 units sold in Q3 2025. Gross margins remained relatively stable but saw a slight compression, moving from 77.6% to 77.3% year-over-year.
Tickers: $SNWV
Topics: earnings report gross margin revenue decline unit sales